We are live on ! Find out more
UONDDL

University of Notre Dame du Lac Portfolio holdings

AUM $66.8M
1-Year Est. Return 43.52%
This Fund
S&P 500
This Quarter Est. Return
+6.88%
1 Year Est. Return
+43.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$338M
AUM Growth
-$61.7M
Cap. Flow
-$77.6M
Cap. Flow %
-22.93%
Top 10 Hldgs %
28.59%
Holding
94
New
24
Increased
14
Reduced
34
Closed
21

Top Buys

Rank Stock Value
1
JD icon
JD.com
JD
+$19M
2
LBTYA icon
Liberty Global Class A
LBTYA
+$4.55M
3
MTSI icon
MACOM Technology Solutions
MTSI
+$4.48M
4
VSM
Versum Materials, Inc.
VSM
+$4.39M
5
BLK icon
Blackrock
BLK
+$4.36M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$16.1M
2
CHTR icon
Charter Communications
CHTR
+$11.7M
3
CC icon
Chemours
CC
+$7.25M
4
AVGO icon
Broadcom
AVGO
+$6.44M
5
AMZN icon
Amazon
AMZN
+$6.4M

Sector Composition

Rank Sector Weight
1 Healthcare 26.63%
2 Financials 15.39%
3 Technology 14.49%
4 Communication Services 10.24%
5 Industrials 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VWO icon
51
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$4.02M 1.19%
98,352
+24,893
+34% +$1.01M
CSOD
52
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$3.97M 1.17%
111,027
-34,131
-24% -$1.28M
TWTR
53
DELISTED
Twitter, Inc.
TWTR
$3.96M 1.17%
+221,592
New +$3.78M
AAPL icon
54
Apple
AAPL
$4.44T
$3.94M 1.17%
109,472
-69,464
-39% -$2.57M
ALNY icon
55
Alnylam Pharmaceuticals
ALNY
$29.7B
$2.98M 0.88%
+37,408
New +$2.39M
ONC
56
BeOne Medicines Ltd
ONC
$40.6B
$2.94M 0.87%
65,454
+2,243
+4% +$88.4K
SAGE
57
DELISTED
Sage Therapeutics
SAGE
$2.78M 0.82%
34,936
-3,715
-10% -$269K
LH icon
58
Labcorp
LH
$25.9B
$2.71M 0.8%
+20,449
New +$2.5M
ABMD
59
DELISTED
Abiomed Inc
ABMD
$2.63M 0.78%
18,355
-2,473
-12% -$332K
GHDX
60
DELISTED
Genomic Health, Inc.
GHDX
$2.61M 0.77%
80,135
+442
+0.6% +$14K
UTHR icon
61
United Therapeutics
UTHR
$22.2B
$2.6M 0.77%
20,063
+2,821
+16% +$352K
HUM icon
62
Humana
HUM
$45.5B
$2.57M 0.76%
+10,683
New +$2.42M
DBVT
63
DBV Technologies
DBVT
$896M
$2.52M 0.74%
7,054
+82
+1% +$28K
NKTR icon
64
Nektar Therapeutics
NKTR
$2.56B
$2.44M 0.72%
8,309
-3,379
-29% -$976K
INSM icon
65
Insmed
INSM
$29.4B
$2.42M 0.71%
140,761
-16,768
-11% -$286K
NGNE icon
66
Neurogene
NGNE
$724M
$2.41M 0.71%
+8,561
New +$2.45M
BCRX icon
67
BioCryst Pharmaceuticals
BCRX
$2.63B
$2.35M 0.69%
422,767
+100,603
+31% +$613K
EPZM
68
DELISTED
Epizyme, Inc
EPZM
$2.32M 0.68%
+153,351
New +$2.32M
AMAG
69
DELISTED
AMAG Pharmaceuticals
AMAG
$2.27M 0.67%
123,140
+18,538
+18% +$367K
AKAO
70
DELISTED
Achaogen Inc
AKAO
$2.26M 0.67%
+103,868
New +$2.37M
TGTX icon
71
TG Therapeutics
TGTX
$7.68B
$2.13M 0.63%
+211,927
New +$2.37M
SGEN
72
DELISTED
Seagen Inc. Common Stock
SGEN
$2.03M 0.6%
39,295
+2,049
+6% +$130K
VNQ icon
73
Vanguard Real Estate ETF
VNQ
$38.4B
$1.3M 0.39%
15,653
+6,180
+65% +$515K
AIG icon
74
American International
AIG
$40.2B
– –
-90,298
Closed -$5.64M
AMRN
75
Amarin Corp
AMRN
$301M
– –
-38,462
Closed -$2.46M
1 2
3
4

Similar funds

PPL
PATRIZIA Pty Ltd Barton, Australia $67.3M AUM 26.18% 1-Year Est. Return
ACH
Avista Capital Holdings New York $68.4M AUM 23% 1-Year Est. Return
TM
Titan Managers Scottsdale, Arizona $63.6M AUM 0.03% 1-Year Est. Return
SVG
Sun Valley Gold Sun Valley, Idaho $63.2M AUM 182.76% 1-Year Est. Return
DLDF
Dan L. Duncan Foundation Houston, Texas $70.6M AUM 22.88% 1-Year Est. Return
AGFIA
Accel Growth Fund IV Associates Palo Alto, California $58.7M AUM 25.19% 1-Year Est. Return
ARC
Arias Resource Capital George Town, Grand Cayman, Cayman Islands $58.6M AUM 26.15% 1-Year Est. Return
ST
SAL Trading Bala Cynwyd, Pennsylvania $57M AUM 33.89% 1-Year Est. Return

University of Notre Dame du Lac's Q2 2017 Portfolio in Review

As of Q2 2017, University of Notre Dame du Lac held 94 positions worth $338M, down 15% from $400M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

University of Notre Dame du Lac withdrew a net $77.6M in Q2 2017, closing 21 positions and reducing 34 holdings. Its most notable exit was Chemours, an estimated $7.25M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 24% a quarter earlier, followed by Financials and Technology.

Against the trend, University of Notre Dame du Lac opened a new position in JD.com worth $19.8M.

  • University of Notre Dame du Lac's largest Q2 2017 buy was JD.com: 504,600 shares worth $19.8M.
  • University of Notre Dame du Lac added most to Medicines Co in Q2 2017, an estimated $4.09M increase.
  • University of Notre Dame du Lac's biggest Q2 2017 reduction was Alphabet (Google) Class C, cutting an estimated $16.1M.
  • University of Notre Dame du Lac fully exited Chemours in Q2 2017, selling an estimated $7.25M.
  • University of Notre Dame du Lac's ten largest holdings make up 29% of its $338M portfolio in Q2 2017.
  • University of Notre Dame du Lac opened 24 new positions and closed 21 in Q2 2017.
  • University of Notre Dame du Lac's portfolio value fell 15% quarter-over-quarter to $338M.

Based on University of Notre Dame du Lac's 13F filing for Q2 2017, filed 11 Aug 2017.